Iradimed (NASDAQ:IRMD) Issues FY 2025 Earnings Guidance

Iradimed (NASDAQ:IRMD) issued an update on its FY 2025 earnings guidance on Thursday morning. The company provided EPS guidance of 1.710-1.810 for the period, compared to the consensus EPS estimate of 1.750. The company issued revenue guidance of $78.0 million-$82.0 million, compared to the consensus revenue estimate of $80.7 million. Iradimed also updated its Q1 2025 guidance to 0.390-0.430 EPS.

Iradimed Stock Down 8.4 %

Shares of NASDAQ:IRMD opened at $55.40 on Friday. The business has a 50 day moving average price of $57.16 and a 200 day moving average price of $52.02. Iradimed has a twelve month low of $40.18 and a twelve month high of $63.29. The company has a market cap of $701.92 million, a price-to-earnings ratio of 37.95 and a beta of 0.82.

Iradimed (NASDAQ:IRMD) last announced its earnings results on Thursday, February 13th. The medical equipment provider reported $0.40 earnings per share for the quarter, missing the consensus estimate of $0.45 by ($0.05). Iradimed had a net margin of 26.12% and a return on equity of 23.99%. Analysts anticipate that Iradimed will post 1.52 EPS for the current year.

Analyst Ratings Changes

Separately, StockNews.com downgraded Iradimed from a “strong-buy” rating to a “buy” rating in a research report on Thursday.

Insider Activity at Iradimed

In related news, CFO John Glenn sold 2,500 shares of the firm’s stock in a transaction on Monday, December 2nd. The stock was sold at an average price of $54.18, for a total transaction of $135,450.00. Following the completion of the sale, the chief financial officer now directly owns 4,383 shares of the company’s stock, valued at $237,470.94. This trade represents a 36.32 % decrease in their position. The transaction was disclosed in a document filed with the SEC, which is available at this hyperlink. Insiders own 37.10% of the company’s stock.

Iradimed Company Profile

IRadimed Corp. engages in the development, manufacture, marketing, and distribution of Magnetic Resonance Imaging compatible medical devices. It also provides a non-magnetic Intravenous infusion pump system that is specifically designed for use during MRI procedures. The company was founded by Roger Susi in July 1992 and is headquartered in Winter Springs, FL.